Selective HDAC6 Inhibitor ACY 241 in Combination With Nivolumab in Patients With Unresectable Non Small Cell Lung Cancer
Clinical trial NCT02635061 · TERMINATED
Trial details
- NCT number
- NCT02635061
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-25
- Primary completion
- 2024-01-22
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.